Stork Therapeutics, Inc. — Form D

Stork Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-08. The offering totals $2.7M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-05-08
• Form: D
• Accession: 0002059988-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.7M
• Amount sold: $1.3M
• Remaining: $1.4M
• Investors: 3
• Date of first sale: 2025-04-24
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-545504

Issuer

• Name: Stork Therapeutics, Inc.
• CIK: 0002059988
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 325 15TH AVENUE, SAN FRANCISCO, CA, 94118
• Phone: (415) 699-7583

Officers, directors & promoters (4)

More

• CIK 2059988 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search